Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Matters Arising
  • Published:

Reply to: Apolipoprotein C3 induces inflammasome activation only in its delipidated form

The Original Article was published on 13 February 2023

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Modification of the association between an Nlrp3 activating genetic variant and cardiovascular mortality by triglycerides and ApoC3.

References

  1. Zewinger, S. et al. Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation. Nat. Immunol. 21, 30–41 (2020).

    Article  CAS  PubMed  Google Scholar 

  2. Hsu, C.-C. et al. Apolipoprotein C3 induces inflammasome activation only in its delipidated form. Nat. Immunol. https://doi.org/10.1038/s41590-023-01424-1 (2023).

  3. Zheng, C., Khoo, C., Furtado, J. & Sacks, F. M. Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype. Circulation 121, 1722–1734 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Mehta, A. & Shapiro, M. D. Apolipoproteins in vascular biology and atherosclerotic disease. Nat. Rev. Cardiol. 19, 168–179 (2022).

    Article  CAS  PubMed  Google Scholar 

  5. Tam, S. P., Dory, L. & Rubinstein, D. Fate of apolipoproteins C-1, C-iii, and E during lipolysis of human very low density lipoproteins in vitro. J. Lipid Res. 22, 641–651 (1981).

    Article  CAS  PubMed  Google Scholar 

  6. Schunk, S. J. et al. Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality. Eur. Heart J. 42, 1742–1756 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

S.Z., W.M., U.L., and T.S. wrote the manuscript. S.Z. and T.S. performed the analyses. J.R., V.J., D.A., E.H., S.T., M.K., S.J.S., D.S., R.K., C.K., E.A., M.W.L., S.R.S., A.P., T.H., S.G., G.S., M.S., U.S., G.A., R.B., G.K., W.J.D., M.D.M., L.R., M.B., J.J., M.K., E.L., B.A.N., and D.F. critically revised the manuscript.

Corresponding author

Correspondence to Thimoteus Speer.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zewinger, S., Reiser, J., Jankowski, V. et al. Reply to: Apolipoprotein C3 induces inflammasome activation only in its delipidated form. Nat Immunol 24, 412–413 (2023). https://doi.org/10.1038/s41590-023-01424-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41590-023-01424-1

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing